Activated microglia in the human glaucomatous optic nerve head.

Area of Science:

• Neuroscience
• Immunology
• Ophthalmology

Background:

• Microglia are the resident immune cells of the central nervous system.
• Glaucoma is a progressive optic neuropathy characterized by damage to the optic nerve head (ONH).
• The role of microglia in the pathogenesis of glaucoma is not fully understood.

Purpose of the Study:

• To investigate the distribution and activation state of microglia in the ONH of normal and glaucomatous eyes.
• To identify specific functional proteins expressed by microglia in glaucoma.
• To explore the potential role of microglia in the pathological process of glaucomatous optic neuropathy.

Main Methods:

• Histological analysis of optic nerve sections from normal and glaucoma patients.
• Double labeling immunohistofluorescence using antibodies against HLA-DR (activated microglia) and various functional proteins.
• Colocalization studies to assess the expression of cytokines, enzymes, and matrix proteins in microglia.

Main Results:

• Microglia in normal ONHs express constitutive proteins like MMPs, COX-1, TNF-R1, TIMP-1, and c-fms.
• In glaucomatous ONHs, microglia show increased expression of TGF-beta2, TNF-alpha, PCNA, COX-2, and other markers, indicating activation and phagocytic activity.
• Expression of certain matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) is altered in glaucomatous ONHs.

Conclusions:

• Activated microglia in glaucoma produce cytokines, mediators, and enzymes that can modify the extracellular matrix.
• Early in glaucoma, activated microglia may play a protective role, but their activity can become detrimental as the disease progresses.
• Microglial activation is a significant feature of glaucomatous optic neuropathy and influences its pathological course.